____________________________ Responsibilities and Requirements of Prescribing Schedule II Opioid Drugs DCA02OP — 2 CE CREDIT HOURS R elease D ate : 02/01/24 E xpiration D ate : 01/31/27 Responsibilities and Requirements of Prescribing Schedule II Opioid Drugs
Audience This course is designed for dental professionals who may alter prescribing practices or intervene to prevent drug diversion and inappropriate opioid use. Course Objective The purpose of this course is to provide dental professionals who prescribe or distribute opioids with an appreciation for the complexities of opioid prescribing and the dual risks of litigation due to inadequate pain control and drug diversion or misuse in order to provide the best possible patient care and to prevent a growing social problem. Learning Outcomes Upon completion of this course, you should be able to: 1. Apply epidemiologic trends in opioid use and misuse to current practice so at-risk patient populations can be more easily identified, assessed, and treated. 2. Outline practices for pain management in dentistry. 3. Evaluate behaviors that may indicate drug seeking or diverting as well as approaches for patients suspected of misusing opioids. 4. Discuss the regulatory requirements for prescribers and dispensers. 5. Describe the dental office procedures for managing vulnerable or substance use disorder patients. Faculty Mark Rose, BS, MA, LP , is a licensed psychologist in the State of Minnesota with a private consulting practice and a medical research analyst with a biomedical communications firm. Earlier healthcare technology assessment work led to medical device and pharmaceutical sector experience in new product development involving cancer ablative devices and pain therapeutics. Along with substantial experience in addic- tion research, Mr. Rose has contributed to the authorship of numerous papers on CNS, oncology, and other medical
disorders. He is the lead author of papers published in peer- reviewed addiction, psychiatry, and pain medicine journals and has written books on prescription opioids and alcoholism published by the Hazelden Foundation. He also serves as an Expert Advisor and Expert Witness to law firms that represent disability claimants or criminal defendants on cases related to chronic pain, psychiatric/substance use disorders, and acute pharmacologic/toxicologic effects. Mr. Rose is on the Board of Directors of the Minneapolis-based International Institute of Anti-Aging Medicine and is a member of several professional organizations. Faculty Disclosure Contributing faculty, Mark Rose, BS, MA, LP, has disclosed no relevant financial relationship with any product manufacturer or service provider mentioned. Division Planner Mark J. Szarejko, DDS, FAGD Senior Director of Development and Academic Affairs Sarah Campbell Division Planner/Director Disclosure The division planner and director have disclosed no relevant financial relationship with any product manufacturer or service provider mentioned. Accreditations & Approvals NetCE is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. Concerns or complaints about a CE provider may be directed to the provider or to ADA CERP at www.ada.org/cerp. NetCE Nationally Approved PACE Program Provider for FAGD/MAGD credit. Approval does not imply acceptance by any regulatory authority or AGD endorsement.
10/1/2021 to 9/30/2027 Provider ID #217994.
Mention of commercial products does not indicate endorsement.
121
EliteLearning.com/Dental
Powered by FlippingBook